Toxicity of cyclosporine metabolites
- PMID: 2274998
- DOI: 10.1097/00007691-199011000-00003
Toxicity of cyclosporine metabolites
Abstract
Eight cyclosporine (CsA) metabolites were isolated from the urine of renal transplant recipients. The structure and purity of the metabolites were characterized by fast atom bombardment/mass spectroscopy as well as by proton and 13C nuclear magnetic resonance. The in vitro toxicity of the metabolites were tested using a porcine renal epithelial cell line (LLC-PK1). None of the metabolites was as effective as CsA in inhibiting cell growth and DNA, RNA, or protein synthesis, with the majority of them exhibiting activity less than 10% of that of CsA when the IC50 (the concentration required for 50% inhibition of that particular metabolic function) values were compared. The exception to this was the demethylated metabolite M-21, which exhibited a potency of 17-50% of CsA for the various metabolic parameters examined. The results suggest that the immunosuppressive activity of metabolites may be dissociated from their toxicity. Morphologically, CsA and the metabolite M-21 resulted in changes consistent with the vacuolization seen in tubular cells exposed to CsA in vivo. In contrast, M-17 up to the maximum concentration tested (25,000 micrograms/L) was found not to cause such changes.
Similar articles
-
Immunosuppressive activity of cyclosporine metabolites compared and characterized by mass spectroscopy and nuclear magnetic resonance.Clin Chem. 1990 Feb;36(2):225-9. Clin Chem. 1990. PMID: 2137384
-
The clinical significance of cyclosporine metabolites.Clin Biochem. 1991 Feb;24(1):23-35. doi: 10.1016/0009-9120(91)90126-y. Clin Biochem. 1991. PMID: 2060129 Review.
-
Pharmacokinetics and biotransformation of the cyclosporine metabolite M-17 in the rabbit.Drug Metab Dispos. 1990 Mar-Apr;18(2):226-30. Drug Metab Dispos. 1990. PMID: 1971578
-
The isolation, structural characterization, and immunosuppressive activity of cyclosporin G (NVa2-cyclosporine) metabolites.Ther Drug Monit. 1991 Jul;13(4):281-8. doi: 10.1097/00007691-199107000-00001. Ther Drug Monit. 1991. PMID: 1780958
-
Comparison of the effects of cyclosporin G (OG37-325), cyclosporin A, and their metabolites on the release of endothelin and prostacyclin from primary renal and aortic endothelial cell lines.Ther Drug Monit. 1994 Oct;16(5):450-7. doi: 10.1097/00007691-199410000-00003. Ther Drug Monit. 1994. PMID: 7846742
Cited by
-
Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients.Br J Clin Pharmacol. 2003 Feb;55(2):203-11. doi: 10.1046/j.1365-2125.2003.01759.x. Br J Clin Pharmacol. 2003. PMID: 12580993 Free PMC article. Clinical Trial.
-
CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine disposition.Transplantation. 2013 Mar 27;95(6):821-7. doi: 10.1097/TP.0b013e31827e6ad9. Transplantation. 2013. PMID: 23354298 Free PMC article.
-
A review of assay methods for cyclosporin. Clinical implications.Clin Pharmacokinet. 1992 Sep;23(3):173-90. doi: 10.2165/00003088-199223030-00002. Clin Pharmacokinet. 1992. PMID: 1511535 Review.
-
The genetics of kidney transplantation.Hum Genet. 2012 Mar;131(3):317-23. doi: 10.1007/s00439-011-1092-8. Epub 2011 Sep 16. Hum Genet. 2012. PMID: 21922316 Review.
-
Use of human organ slices to evaluate the biotransformation and drug-induced side-effects of pharmaceuticals.Cell Biol Toxicol. 1994 Dec;10(5-6):407-14. doi: 10.1007/BF00755790. Cell Biol Toxicol. 1994. PMID: 7697504
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources